Cover Image
市場調查報告書

血液腫瘤:全球臨床實驗檢討 (2015年前期)

Hematological Tumor Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 242652
出版日期 內容資訊 英文 102 Pages
訂單完成後即時交付
價格
Back to Top
血液腫瘤:全球臨床實驗檢討 (2015年前期) Hematological Tumor Global Clinical Trials Review, H1, 2015
出版日期: 2015年03月16日 內容資訊: 英文 102 Pages
簡介

本報告提供全球血液腫瘤治療藥臨床實驗相關調查、各地區的臨床試驗數資料、實驗階段、實驗狀況、各採用主題及類型贊助企業的臨床實驗資料、中斷 (暫時停止、廢止、停止) 的實驗的清單等。

目錄

  • 簡介
  • 血液腫瘤
  • 報告指南
  • 臨床試驗:各地區
  • 臨床試驗:各國
  • 對臨床實驗有所貢獻的主要5個國家 - 亞太地區
  • 對臨床實驗有所貢獻的主要5個國家 - 歐洲
  • 對臨床實驗有所貢獻的主要國家 - 北美
  • 對臨床實驗有所貢獻的主要國家 - 中東及非洲
  • 對臨床實驗有所貢獻的主要國家 - 中南美
  • 臨床試驗 G7 各國:癌症臨床試驗的血液腫瘤比率
  • 臨床試驗 G7 各國:各相位
  • 臨床試驗 G7 各國:各臨床實驗狀態
  • 臨床試驗 E7 各國:癌症臨床試驗的血液腫瘤比率
  • 臨床試驗 E7 各國:各相位
  • 臨床試驗 E7 各國:各臨床實驗狀態
  • 各Phase臨床試驗
  • 進行中的臨床實驗:各相位
  • 臨床試驗:各臨床實驗狀態
  • 臨床試驗:各試驗指標狀態
  • 未完成的臨床實驗:血液腫瘤
  • 每段時期的實驗人數
  • 臨床試驗:各贊助商類型
  • 有力的贊助商
  • 主要的臨床實驗參加企業
  • 潛力治療藥物
  • 臨床試驗簡介
  • 臨床試驗概要: 主要企業 / 研究機關 / 大學
  • Novartis AG
  • GlaxoSmithKline plc
  • Sanofi
  • Pfizer Inc.
  • AstraZeneca PLC
  • Amgen Inc.
  • 武田藥品工業
  • Bellicum Pharmaceuticals, Inc.
  • National Cancer Institute
  • University of Texas M. D. Anderson Cancer Center
  • Fred Hutchinson Cancer Research Center
  • Roswell Park Cancer Institute
  • Thomas Jefferson University
  • Baylor College of Medicine
  • Memorial Sloan Kettering Cancer Center
  • Masonic Cancer Center
  • National Cancer Center Hospital
  • University of California, San Francisco

附錄

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2581CTIDB

GlobalData's clinical trial report, "Hematological Tumor Global Clinical Trials Review, H1, 2015" provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematological Tumor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hematological Tumor
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hematological Tumor to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hematological Tumor to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hematological Tumor
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hematological Tumor Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Infinity Pharmaceuticals, Inc.
      • Clinical Trial Overview of Infinity Pharmaceuticals, Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Bellicum Pharmaceuticals, Inc.
      • Clinical Trial Overview of Bellicum Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
      • Fred Hutchinson Cancer Research Center
      • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
      • Roswell Park Cancer Institute
      • Clinical Trial Overview of Roswell Park Cancer Institute
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Masonic Cancer Center
      • Clinical Trial Overview of Masonic Cancer Center
      • National Cancer Center Hospital
      • Clinical Trial Overview of National Cancer Center Hospital
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hematological Tumor Therapeutics, Global, Clinical Trials by Region, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Hematological Tumor to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hematological Tumor to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hematological Tumor Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Hematological Tumor Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Hematological Tumor Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hematological Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Bellicum Pharmaceuticals, Inc., 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015*

List of Figures

  • Hematological Tumor Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Hematological Tumor to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hematological Tumor to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hematological Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top